Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / *W EXP 09/01/203
-
Total 13F shares
-
1,151,794
-
Share change
-
+889,809
-
Total reported value
-
$941,930
-
Price per share
-
$0.88
-
Number of holders
-
12
-
Value change
-
+$711,696
-
Number of buys
-
10
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) as of Q4 2024
As of 31 Dec 2024,
Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,151,794 shares.
The largest 10 holders included
AQR Arbitrage LLC, Decagon Asset Management LLP, Shaolin Capital Management LLC, Walleye Capital LLC, GRITSTONE ASSET MANAGEMENT LLC, ExodusPoint Capital Management, LP, TENOR CAPITAL MANAGEMENT Co., L.P., Sculptor Capital LP, K2 PRINCIPAL FUND, L.P., and Verition Fund Management LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.